Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
Natures Sunshine Products executive Bryant J. Yates reported an administrative change to his equity awards. On March 6, 2026, he was granted 7,761 restricted stock units that were scheduled to vest in three equal annual installments through March 6, 2029. The company later rescinded and cancelled all 7,761 units on March 24, 2026, before any had vested. Following this update, Yates directly holds 77,393 common shares.
NATURES SUNSHINE PRODUCTS INC reported an administrative change to equity compensation for executive Daniel C. Norman, EVP & President, Asia. On March 6, 2026, the company granted him 10,088 restricted stock units that were scheduled to vest in three equal annual installments through March 6, 2029.
On March 24, 2026, the company rescinded and cancelled all 10,088 restricted stock units before any had vested. Following this adjustment, Norman’s reported direct holding stands at 41,995 common shares. The Form 4 reflects this as an “other” type of transaction rather than a buy or sell in the open market.
NATURES SUNSHINE PRODUCTS INC reported an administrative equity compensation change for its SVP and Chief Accounting Officer, Jonathan David Lanoy. On March 6, 2026, the company granted 5,415 restricted stock units scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all 5,415 units, and none had vested before cancellation. Following this activity, Lanoy directly holds 40,990 common shares.
Nature’s Sunshine Products Inc. reported an administrative equity change for EVP & Chief Financial Officer Leslie Shane Jones. On March 6, 2026, the company granted 11,798 restricted stock units that were scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all of these units before any had vested. Following this non-market restructuring, Jones directly held 104,528 common shares.
NATURES SUNSHINE PRODUCTS INC reported an administrative change in equity compensation for EVP & President, North America, Herbert Kevin R. The company granted 7,124 restricted stock units on March 6, 2026, scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all 7,124 units before any had vested, so this did not result in vested equity or cash proceeds and reflects a non-market, restructuring-type adjustment to his compensation.
NATURES SUNSHINE PRODUCTS INC reported a compensation adjustment for EVP and General Counsel Nathan G. Brower. On March 6, 2026, the company granted him 7,250 restricted stock units scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all 7,250 units before any had vested. Following these changes, Brower directly holds 43,634 common shares.
NATURES SUNSHINE PRODUCTS INC executive Bryant J. Yates, EVP & President, Europe, reported an open-market sale of 19,516 Common Shares on March 13, 2026 at an average price of $24.35 per share. After this transaction, he directly holds 85,154 Common Shares.
Natures Sunshine Products EVP & President, Asia Daniel C. Norman reported two stock transactions involving the company’s common shares. On March 13, 2026, he completed an open-market sale of 15,383 common shares at an average price of $24.52 per share, leaving him with 55,693 shares immediately after the sale.
On the same date, he disposed of an additional 3,610 common shares through a bona fide charitable gift, for which a footnote states no consideration was received. The footnote adds that the $24.49 price reflects the volume-weighted average share price on the gift date. Following the gift, his direct holdings totaled 52,083 common shares.
NATURES SUNSHINE PRODUCTS INC senior vice president and chief accounting officer Jonathan David Lanoy sold 4,000 common shares in an open-market transaction. The shares were sold at $24.70 per share, and he now directly holds 46,405 common shares following this sale.
Natures Sunshine Products executive Daniel C. Norman, EVP & President, Asia, reported routine tax-withholding transactions related to vested restricted stock units. On March 10 and 11, 2026, a total of 3,091 Common Shares of NATR were withheld to cover taxes, leaving him with 71,076 Common Shares held directly. These Form 4 entries are coded as F, indicating payment of tax liabilities by delivering shares rather than open-market sales.